S&P 500: 669.07 +1.0% NASDAQ 100: 600.85 +1.2% Dow Jones: 470.18 +0.8%

Eli Lilly and Company

LLY Healthcare
$977.09 $-7.99 (-0.81%)
Market Cap: $872.89 B
Gurus Holding
18
Popularity Rank
#58
% of Shares Held
0.75%
Net Activity (Q4 2025)
+$395.68 M

Guru Ownership Trend

Guru Analysis for Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 18 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $6.54 B.

Top institutional holders include Ken Fisher and Jeremy Grantham.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $395.68 M net inflow during the quarter.

Recent activity highlights Steven Cohen who increased their stake by 851.6%. Conversely, Jefferies Group reduced exposure by 79.9%.

Key Holders

Top 5 by Value

$4.95 B
$794.48 M
$544.69 M
$371.14 M

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$666.97 M
Total Buy Value
New Buys 5
Additions 6
-$271.29 M
Total Sell Value
Reductions 6
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
6
Net Buyers
11

FAQs for Eli Lilly and Company (LLY)

Major holders include Ken Fisher ($4.95 B), Jeremy Grantham ($794.48 M), Cliff Asness ($544.69 M). According to the latest reported data, 18 tracked investment managers collectively hold approximately 6.69 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $395.68 M, with 11 managers increasing positions and 6 managers reducing holdings.

During the most recent reporting period, 6 managers trimmed their positions, while 0 fully exited LLY. The total reported sell value was $271.29 M.

Yes, 5 managers opened new positions in LLY, and 6 increased their existing holdings. The total reported buy value was $666.97 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
1.69% Add 3.4% 4,606,327 $4.95 B Q4 2025
2.03% Add 5.5% 739,274 $794.48 M Q4 2025
0.29% Add 12.3% 506,839 $544.69 M Q4 2025
3.57% Reduce -3.6% 345,345 $371.14 M Q4 2025
0.28% New Buy 165,847 $178.23 M Q4 2025
0.29% Add 602.0% 73,292 $78.77 M Q4 2025
0.08% Add 851.6% 67,746 $72.81 M Q4 2025
0.33% Reduce -79.9% 60,336 $64.84 M Q4 2025
0.09% New Buy 46,758 $50.25 M Q4 2025
0.26% Reduce -0.4% 24,876 $26.73 M Q4 2025
0.28% New Buy 22,334 $24 M Q4 2025
0.04% Add 41.1% 11,308 $12.15 M Q4 2025
0.17% New Buy 11,000 $11.82 M Q4 2025
0.06% Reduce -3.3% 4,106 $4.41 M Q4 2025
0.67% 2,000 $2.15 M Q4 2025
0.09% Reduce -8.2% 563 $605,045 Q4 2025
0.03% New Buy 327 $351,441 Q4 2025
0.00% Reduce -25.5% 41 $44,270 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form